Email this page
Print
Bookmark and share
Bigger
Smaller
RSS feedFor consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Quick Links
Articles on varenicline from NPS RADARArticles on varenicline from NPS RADAR
(VA-ren-i-kleen)
| Title | Content Type | Date | Description |
|---|---|---|---|
| Varenicline (Champix) safety update: possible increase in serious cardiovascular events | Professional publication - NPS RADAR - Brief item | 2011-08-01 00:00:00 | Varenicline (Champix) — possible increase in serious cardiovascular events |
| Varenicline (Champix) for smoking cessation | Professional publication - NPS RADAR - Review | 2011-08-01 00:00:00 | New PBS listing for extension to treatment. Smokers who are abstinent at 12 weeks after starting varenicline can now receive a further 12 weeks of treatment to improve their chance of longer-term abstinence. |
| Varenicline (Champix) — new PBS listing for extra 12 weeks of therapy | Professional publication - NPS RADAR - Brief item | 2011-02-01 00:00:00 | From 1 February 2011, under a new authority listing, varenicline (Champix) can be prescribed for a further 12 weeks for people who respond to an initial 12 weeks of varenicline and who are enrolled in a support and counselling program, as an aid to remaining abstinent. |
| Varenicline (Champix) safety update: serious neuropsychiatric and dermatological adverse events | Professional publication - NPS RADAR - Brief item | 2009-12-01 00:00:00 | Serious neuropsychiatric symptoms and severe skin reactions have been reported in people taking varenicline. Updated advice on managing neuropsychiatric symptoms and a precaution about rare but potentially fatal skin reactions have been added to the product information. |
View all RADAR articles by date, by therapeutic topic, or by active ingredient, or find out more about NPS RADAR.
NPS RADAR: independent, evidence-based assessment of new drugs, new PBS listings and the latest research for doctors, pharmacists and other health professionals.
Date published: 2009-10-30 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
